# Anaptysbio, Inc: Form 10-KT, filed Sep 21, 2026

- Company: [Anaptysbio, Inc](/companies/anab.md) (CIK 1370053)
- Form: 10-KT
- Filed: 2026-09-21
- Accepted by EDGAR: Sep 21, 2026, 16:23 ET
- Period: 2026-06-30
- Accession: 0001193125-26-396696
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1370053/000119312526396696/anab-20260630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1370053/000119312526396696/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 6 months, 2026-01-01 to 2026-06-30 | $53.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Operating income | 6 months, 2026-01-01 to 2026-06-30 | $32.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 6 months, 2026-01-01 to 2026-06-30 | −$181.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 6 months, 2026-01-01 to 2026-06-30 | $131.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 6 months, 2026-01-01 to 2026-06-30 | $3.50 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 6 months, 2026-01-01 to 2026-06-30 | $4.52 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 6 months, 2026-01-01 to 2026-06-30 | 37,476,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2026-01-01 to 2026-06-30 | −$52.6m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 6 months, 2026-01-01 to 2026-06-30 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-06-30 | $133.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-06-30 | $198.4m | us-gaap:AssetsCurrent |
| Total assets | at 2026-06-30 | $317.0m | us-gaap:Assets |
| Current liabilities | at 2026-06-30 | $35.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2026-06-30 | $10.6m | us-gaap:StockholdersEquity |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1370053/000119312526396696/anab-20260630.htm

Filed Sep 21, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-396696. Last ingested by Listed: Nov 13, 2026, 16:10 ET. No prices; not investment advice.
